MADRID, 28 (EUROPA PRESS)
PharmaMar’s shares will begin trading on the Ibex Medium Cap on November 2, once the reverse merger process with its parent company Zeltia has been completed, which will be excluded from this index, as reported by the Ibex technical advisory committee.
Facebook Comments
Disqus